کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2948833 | 1577294 | 2010 | 11 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Rebuilding the Damaged Heart : The Potential of Cytokines and Growth Factors in the Treatment of Ischemic Heart Disease Rebuilding the Damaged Heart : The Potential of Cytokines and Growth Factors in the Treatment of Ischemic Heart Disease](/preview/png/2948833.png)
Cytokine therapy promises to provide a noninvasive treatment option for ischemic heart disease. Cytokines are thought to influence angiogenesis directly via effects on endothelial cells or indirectly through progenitor cell-based mechanisms or by activating the expression of other angiogenic agents. Several cytokines mobilize progenitor cells from the bone marrow or are involved in the homing of mobilized cells to ischemic tissue. The recruited cells contribute to myocardial regeneration both as a structural component of the regenerating tissue and by secreting angiogenic or antiapoptotic factors, including cytokines. To date, randomized, controlled clinical trials have not reproduced the efficacy observed in pre-clinical and small-scale clinical investigations. Nevertheless, the list of promising cytokines continues to grow, and combinations of cytokines, with or without concurrent progenitor cell therapy, warrant further investigation.
Journal: Journal of the American College of Cardiology - Volume 56, Issue 16, 12 October 2010, Pages 1287–1297